Doron Netzer

2.9k total citations · 4 hit papers
37 papers, 1.5k citations indexed

About

Doron Netzer is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Doron Netzer has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 9 papers in Epidemiology and 5 papers in General Health Professions. Recurrent topics in Doron Netzer's work include SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (10 papers) and Vaccine Coverage and Hesitancy (4 papers). Doron Netzer is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (10 papers) and Vaccine Coverage and Hesitancy (4 papers). Doron Netzer collaborates with scholars based in Israel, United States and United Kingdom. Doron Netzer's co-authors include Ran D. Balicer, Noa Dagan, Jacob Waxman, Yatir Ben‐Shlomo, Noam Barda, Ben Y. Reis, Marc Lipsitch, Miguel A. Hernán, Reut Ohana and Eldad Kepten and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Nature Communications.

In The Last Decade

Doron Netzer

33 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

2021 672 citations Noam Barda, Noa Dagan et al. New England Journal of Medicine profile →
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge

2022 197 citations Ronen Arbel, Yael Wolff Sagy et al. New England Journal of Medicine profile →
Real-world effectiveness of a single dose of mpox vaccine in males

2023 119 citations Yael Wolff Sagy, Wiessam Abu Ahmad et al. profile →
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study

2023 86 citations Ronen Arbel, Alon Peretz et al. The Lancet Infectious Diseases profile →

Peers

Countries citing papers authored by Doron Netzer

Since Specialization

Citations

This map shows the geographic impact of Doron Netzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doron Netzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doron Netzer more than expected).

Fields of papers citing papers by Doron Netzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doron Netzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doron Netzer. The network helps show where Doron Netzer may publish in the future.

Co-authorship network of co-authors of Doron Netzer

This figure shows the co-authorship network connecting the top 25 collaborators of Doron Netzer. A scholar is included among the top collaborators of Doron Netzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doron Netzer. Doron Netzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Primary healthcare delivery adaptations in war-induced population displacement 2025 ·Israel Journal of Health Policy Research ·(unknown), Yael Wolff Sagy, Ilan Feldhamer, Shlomit Yaron, (unknown), Doron Netzer, Ronen Arbel, (unknown)	0
2	Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period 2025 ·Infectious Diseases and Therapy ·Samah Hayek, Joseph Levy, (unknown), Noa Dagan, (unknown), Hadar Duskin‐Bitan, Sabada Dube, Cátia Ferreira, (unknown), Carla Talarico, (unknown), Sudhir Venkatesan, (unknown), Ran D. Balicer, Doron Netzer, Alon Peretz	0
3	Increased cancer risk in a cohort of patients with acromegaly in Israel 2025 ·Endocrine Related Cancer ·Hadar Duskin‐Bitan, (unknown), Doron Netzer, Arnon D. Cohen, Doron Comaneshter, (unknown), Shlomit Yaron, (unknown), (unknown), (unknown), Ilan Shimon	1
4	Incremental benefit of high dose compared to standard dose influenza vaccine in reducing hospitalizations 2025 ·npj Vaccines ·Shlomit Yaron, Matan Yechezkel, Dan Yamin, (unknown), (unknown), Erez Shmueli, Ronen Arbel, Doron Netzer	3
5	Bidirectional association between vitiligo and melasma: A large-scale population-based study 2025 ·Indian Journal of Dermatology Venereology and Leprology ·Shany Sherman, (unknown), (unknown), (unknown), (unknown), Assi Levi, Daniel Mimouni, (unknown), John E. Harris, (unknown), Yochai Schonmann, Arnon D. Cohen, Doron Netzer	0
6	The risk of psychiatric disorders in finasteride users with benign prostatic hyperplasia and androgenetic alopecia: A population‐based case–control study 2024 ·Australasian Journal of Dermatology ·Anna Lyakhovitsky, Boaz Amichai, (unknown), Arnon D. Cohen, Khalaf Kridin, Zvi Segal, Doron Netzer	2
7	Fentanyl Initiation Rate Following the Requirement for Specialist Approval 2024 ·Journal of General Internal Medicine ·Oren Miron, (unknown), Mark Levin, (unknown), (unknown), (unknown), Wiessam Abu Ahmad, (unknown), Doron Netzer, Gil Lavie	0
8	Effectiveness and safety of molnupiravir in the intended-use population: an observational cohort study 2024 ·Clinical Microbiology and Infection ·(unknown), Ronen Arbel, Yael Wolff Sagy, Erez Battat, (unknown), Michael Friger, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Doron Netzer	1
9	Evaluation of AI Solutions in Health Care Organizations — The OPTICA Tool 2024 ·NEJM AI ·Noa Dagan, (unknown), (unknown), (unknown), Adir Sommer, (unknown), (unknown), Reut Ohana, Orly Weinstein, Doron Netzer, (unknown), Ran D. Balicer	11
10	Subacute Thyroiditis Following COVID-19 and COVID-19 Vaccination 2024 ·Endocrine Practice ·(unknown), Eyal Robenshtok, Alon Peretz, (unknown), (unknown), Doron Netzer, Arnon D. Cohen, Walid Saliba, Ilan Shimon, Alexander Gorshtein	1
11	Examining the Patterns of Mpox Vaccine Uptake in a Vulnerable Population 2023 ·Sexually Transmitted Diseases ·(unknown), (unknown), (unknown), Yuval Raviv, Gil Lavie, Doron Netzer, (unknown), Ronen Arbel	5
12	Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study 2023 ·The Lancet Infectious Diseases ·Dan Yamin, Matan Yechezkel, Ronen Arbel, (unknown), Ruslan Sergienko, Hadar Duskin‐Bitan, Shlomit Yaron, Alon Peretz, Doron Netzer, Erez Shmueli	19
13	Shared trust of resident physicians in top‐management and professional burnout: A cross‐sectional study towards capacity for patient‐focussed care, peer support and job expectations 2022 ·The International Journal of Health Planning and Management ·Gillie Gabay, Doron Netzer, Asher Elhayany	6
14	BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age 2022 ·New England Journal of Medicine ·Chandra J. Cohen-Stavi, (unknown), Noam Barda, Shlomit Yaron, Alon Peretz, Doron Netzer, Carlo Giaquinto, Ali Judd, Leonard Leibovici, Miguel A. Hernán, Marc Lipsitch, Ben Y. Reis, Ran D. Balicer, Noa Dagan	53
15	Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes 2022 ·Nature Communications ·Samah Hayek, Yatir Ben‐Shlomo, Noa Dagan, Ben Y. Reis, Noam Barda, Eldad Kepten, (unknown), Shachar Shapira, Shlomit Yaron, Ran D. Balicer, Doron Netzer, Alon Peretz	5
16	Community antibiotic prescriptions during COVID-19 era: a population-based cohort study among adults 2022 ·Clinical Microbiology and Infection ·(unknown), Marcelo Low, Doron Netzer, Ronit Almog, Michal Chowers	4
17	Comparing COVID-19-related hospitalization rates among individuals with infection-induced and vaccine-induced immunity in Israel 2022 ·Nature Communications ·Jacob Waxman, (unknown), Ben Y. Reis, Doron Netzer, Ran D. Balicer, Noa Dagan, Noam Barda	16
18	Developing a COVID-19 mortality risk prediction model when individual-level data are not available 2020 ·Nature Communications ·Noam Barda, Dan Riesel, (unknown), Joseph Levy, (unknown), Gal Yona, (unknown), (unknown), Jonathan Somer, Eitan Bachmat, Guy N. Rothblum, Uri Shalit, Doron Netzer, Ran D. Balicer, Noa Dagan	77
19	[Evidence-based clinical database--rational use saves time]. 2010 ·PubMed ·Doron Netzer, (unknown), Doron Hermoni	1
20	Evaluating the impact of an evidence‐based medicine educational intervention on primary care doctors’ attitudes, knowledge and clinical behaviour: a controlled trial and before and after study 2007 ·Journal of Evaluation in Clinical Practice ·Kerem Shuval, (unknown), Doron Netzer, (unknown), Shai Linn, Mayer Brezis, Shmuel Reis	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact